NCT03352037View on ClinicalTrials.gov

18F-FDG PET/MR Imaging for Differentiation of Serous From Non-Serous Pancreatic Cystic Neoplasms: A Pilot Study

NACompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 15, 2017

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Pancreatic Cystic Neoplasms
Interventions
DIAGNOSTIC_TEST

PET scan

Patients with known pancreatic cystic lesions requiring MR imaging for lesion characterization for clinical evaluation will be recruited to undergo 18F-FDG PET/MR imaging after written informed consent.

Trial Locations (1)

M5G 1Z5

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT03352037 - 18F-FDG PET/MR Imaging for Differentiation of Serous From Non-Serous Pancreatic Cystic Neoplasms: A Pilot Study | Biotech Hunter | Biotech Hunter